RSV (Respiratory syncytial virus) is a virus that causes respiratory tract infections. RSV is a negative-sense, single-stranded RNA virus of the family Paramyxoviridae, which includes common respiratory viruses such as those causingmeasles and mumps. RSV is a member of the paramyxovirus subfamily Pneumovirinae.
RSV is a major cause of lower respiratory tract infections and hospital visits during infancy and childhood.
Cat. No. | Product Name | CAS No. | Information |
---|---|---|---|
H1527 |
Ziresovir |
1422500-60-4 | Ziresovir (AK-0529, AK0529) is a novel RSV F-protein inhibitor for treatment of Hospitalized Respiratory Syncytial Virus (RSV) fnfection. |
H1526 |
YM-53403 |
851331-05-0 |
YM-53403 (YM53403)?is a specific anti-respiratory syncytial virus (RSV) agent with EC50 of 0.2 uM in plaque reduction assays; displays 100-fold more potent than ribavirin, an attractive compound for the treatment of RSV infection. |
H1525 |
VP-14637 |
235106-62-4 | VP-14637 (MDT-637) is a novel RSV fusion inhibitor with EC50 of 1.4 nM, reduces RSV replication by inhibition of the F-protein function; does not block RSV adsorption but inhibits RSV-induced cell-cell fusion and binds specifically to RSV-infected cells, specifically interacts with the RSV fusion protein expressed by a T7 vaccinia virus system; the F proteins containing the resistance mutations exhibits greatly reduced binding of VP-14637. |
H1524 |
TMC353121 |
857066-90-1 | TMC353121 is a potent respiratory syncytial virus (RSV) fusion inhibitor with pEC50 of 9.9, shows activity against groups A and B RSV and against a panel of clinical isolates with equal potency (EC50 |
H1523 |
RV521 |
1903763-82-5 | Sisunatovir is a potent, orally active, small-molecule inhibitor of RSV fusion, demonstrates potent antiviral activity across multiple strains of RSV in vitro. |
H1522 |
RSV604 racemate |
676128-62-4 | RSV604 racemate is a racemic mixture, shows less potency against strains of respiratory syncytial virus (RSV) than the S-isomer (RSV604). |
H1521 |
RSV604 R enantiomer |
932108-20-8 | RSV604 R enantiomer is the R-enantiomer of RSV604, which is a potent respiratory syncytial virus (RSV) inhibitor targeting the nucleocapsid protein, is less active against RSV. |
H1520 |
RSV604 |
676128-63-5 | RSV604 (RSV-604) is a potent respiratory syncytial virus (RSV) inhibitor with EC50 of 0.86 uM in XTT assay, targets the nucleocapsid protein and is active post-RSV infection; RSV604 is also equipotent against 40 clinical isolates of RSV with an average EC50 of 0.8 μM by plaque reduction assay; The mutations (N105D, I129L, L139I, and I129L with L139I) within the nucleocapsid protein confer 5->20-fold reduced potentcy for RSV604; inhibits virus replication after mucosal inoculation in human airway epithelial cell model (EC50=0.5-0.9 uM). |
H1519 |
RSV inhibitor compound 1 |
1422496-79-4 | RSV inhibitor compound 1 is a novel potent, orally bioavailable RSV fusion inhibitor with EC50 of 2 nM (RSV Long strain infected HEp-2 cells) without significant cytotoxicity (CC50>100 uM); demonstrats single-digit nM anti-RSV activity against different RSV strains (RSV A2, RSV B with EC50 of 4 and 2 nM); also displays 1 log viral reduction in a female BALB/c mice RSV model by b.i.d. oral dosing at 12.5 mg/kg. |
H1518 |
Presatovir |
1353625-73-6 |
Presatovir (GS-5806) is a novel, orally bioavailable RSV fusion inhibitor with mean EC50 of 0.43 nM against a panel of 75 RSV A and B clinical isolates; exhibits low cytotoxicity in human cell lines and primary cell cultures (selectivity > 23,000-fold); shows excellent antiviral efficacy in the cotton rat model of RSV infection. |
086-18516630705
sales@hmobio.com
1/F, building 4, No. 358-368, Kefu Road, Jiading District, Shanghai, China